Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:26 pm Sale | 2023-12-31 | 13G | DocGo Inc. DCGO | James E. Flynn | 5,320,139 5.120% | -694,611 (-11.55%) | Filing History |
| 2024-02-12 5:25 pm Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | James E. Flynn | 2,007,729 4.690% | -332,389 (-14.20%) | Filing History |
| 2024-02-12 5:24 pm Sale | 2023-12-31 | 13G | Amedisys, Inc. AMED | James E. Flynn | 0 0.000% | -1,794,000 (Position Closed) | Filing History |
| 2024-02-12 5:24 pm Purchase | 2023-12-31 | 13G | Brookdale Senior Living Inc. BKD | James E. Flynn | 14,793,264 7.860% | 2,113,613 (+16.67%) | Filing History |
| 2024-02-12 5:23 pm Sale | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | James E. Flynn | 869,565 3.390% | -869,565 (-50.00%) | Filing History |
| 2024-02-12 5:23 pm Purchase | 2023-12-31 | 13G | AdaptHealth Corp. AHCO | James E. Flynn | 27,654,923 9.980% | 5,981,026 (+27.60%) | Filing History |
| 2024-02-01 5:29 pm Purchase | 2024-01-23 | 13G | CalciMedica, Inc. CALC | James E. Flynn | 2,613,012 9.990% | 2,336,214 (+844.01%) | Filing History |
| 2024-02-01 5:28 pm Purchase | 2024-01-23 | 13G | Edgewise Therapeutics, Inc. EWTX | James E. Flynn | 4,478,592 5.250% | 545,455 (+13.87%) | Filing History |
| 2024-02-01 5:26 pm Purchase | 2024-01-24 | 13G | Windtree Therapeutics, Inc. WINT | James E. Flynn | 676 7.590% | 676 (New Position) | Filing History |
| 2024-01-12 3:36 pm Purchase | 2024-01-11 | 13G | Solid Biosciences Inc. SLDB | James E. Flynn | 2,260,398 6.080% | 2,260,398 (New Position) | Filing History |
| 2023-12-18 4:45 pm Purchase | 2023-12-14 | 13G | Fusion Pharmaceuticals Inc. FUSN | James E. Flynn | 6,401,000 8.840% | 6,401,000 (New Position) | Filing History |
| 2023-11-30 5:46 pm Purchase | 2023-11-21 | 13G | Oscar Health, Inc. OSCR | James E. Flynn | 10,537,491 5.520% | 10,537,491 (New Position) | Filing History |
| 2023-11-20 3:19 pm Purchase | 2023-11-14 | 13G | MALLINCKRODT PLC SHS MNKTQ | James E. Flynn | 1,505,969 7.650% | 1,505,969 (New Position) | Filing History |
| 2023-11-13 4:46 pm Purchase | 2023-11-08 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 9,677,857 9.220% | 32,892 (+0.34%) | Filing History |
| 2023-11-13 08:30 am Purchase | 2023-11-02 | 13G | Prelude Therapeutics Incorporated PRLD | James E. Flynn | 3,222,690 7.680% | 3,222,690 (New Position) | Filing History |
| 2023-10-26 4:55 pm Purchase | 2023-10-17 | 13G | Nkarta, Inc. NKTX | James E. Flynn | 3,400,000 6.930% | 1,980,128 (+139.46%) | Filing History |
| 2023-10-20 2:02 pm Sale | 2023-10-11 | 13G | Silk Road Medical, Inc SILK | James E. Flynn | 0 0.000% | -1,396,640 (Position Closed) | Filing History |
| 2023-10-18 4:41 pm Purchase | 2023-10-09 | 13G | DocGo Inc. DCGO | James E. Flynn | 6,014,750 5.800% | 6,014,750 (New Position) | Filing History |
| 2023-10-04 5:09 pm Sale | 2023-10-04 | 13G | Terns Pharmaceuticals, Inc. TERN | James E. Flynn | 0 0.000% | -2,851,287 (Position Closed) | Filing History |
| 2023-10-04 5:08 pm Sale | 2023-10-04 | 13G | Evolus, Inc. EOLS | James E. Flynn | 1,784 0.000% | -3,317,216 (-99.95%) | Filing History |